|
HS Code |
571485 |
| Product Name | 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-Beta-D-Glucosaminide |
| Synonyms | X-GlcNAc |
| Cas Number | 186404-54-2 |
| Molecular Formula | C16H17BrClN2O7 |
| Molecular Weight | 480.67 g/mol |
| Appearance | Powder |
| Color | White to off-white |
| Solubility | Soluble in DMSO, partially soluble in water |
| Storage Temperature | -20°C |
| Application | Chromogenic substrate for N-acetyl-β-D-glucosaminidase |
| Purity | ≥98% (HPLC) |
| Absorption Maximum | 615 nm (after hydrolysis/development) |
As an accredited 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-Beta-D-Glucosaminide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is supplied in a 100 mg amber glass vial, with a screw cap and tamper-evident seal, labeled for laboratory use. |
| Shipping | 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-Beta-D-Glucosaminide is shipped in a tightly sealed container under ambient or refrigerated conditions, depending on supplier recommendations. The package includes appropriate hazard labeling and safety documentation. Ensure the chemical is protected from light, moisture, and excessive heat during transit to maintain stability and prevent degradation. |
| Storage | 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-β-D-Glucosaminide should be stored in a tightly sealed container, protected from light and moisture, at -20°C. Avoid repeated freeze-thaw cycles and exposure to air to maintain stability. Store in a dry environment and keep away from incompatible substances such as strong oxidizing agents. Label appropriately and follow safety guidelines for handling chemical reagents. |
Applications of 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-Beta-D-Glucosaminide in Industrial ManufacturingAs the original manufacturer, we supply 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-Beta-D-Glucosaminide for a range of specialized industrial applications requiring precision substrates in diagnostics, pharmaceutical quality control, and molecular detection. Below we present distinct downstream use cases, focused on industrial requirements, from the perspective of production process, formulation detail, and compliance needs. 1. Clinical In Vitro Diagnostics (IVD) Enzyme Substrate ManufacturingOur material is widely used by IVD reagent producers as a chromogenic substrate in assays targeting glucosaminidase activity. By incorporating it directly into liquid or dry blend enzyme assay kits, manufacturers achieve strong blue chromophore development, supporting accurate colorimetric detection in automated clinical chemistry analyzers. Strict attention to substrate purity, moisture content, and batch-to-batch consistency is essential, given the sensitivity of downstream detection systems. Finished reagents undergo final filling in single-dosed vials or multi-use cartridges for hospital diagnostics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Microbial Culture Media Chromogenic SupplementsIndustrial producers of chromogenic microbiological culture media use the compound to enable direct visual identification of microbial colonies that express N-acetyl-β-D-glucosaminidase activity. Manufacturing often demands precise dispersion in dehydrated media, stable shelf-life during storage, and reliable color development post-autoclaving. Raw substrate requires finely milled powder and controlled particle size distribution to ensure uniformity in large-batch media blending lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Enzyme Screening and High-Throughput Biosensor DevelopmentBiotechnology companies utilize the substrate in the screening of enzyme libraries and biosensor platforms, supporting robust visual and spectrophotometric output for high-throughput routines. Substrate is dispensed into multiwell plates by automated dosing equipment, where concentration uniformity minimizes background and enhances discrimination of positive hits during enzyme evolution or sensor validation projects. Process protocols call for minimal interfering impurities and lot-to-lot reproducibility during bulk integration. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Pharmaceutical Release Testing for Enzyme-Related Drug FormulationsPharmaceutical quality control labs apply this indolyl glucosaminide derivative as a validated substrate for N-acetyl-β-D-glucosaminidase activity release assays in enzyme-containing biopharmaceuticals. Accurate dosimetry and substrate purity allow QC teams to detect minor batch variations in enzyme potency or stability before lot release. Substrate batches undergo identity and assay compliance as part of supplier qualification audits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Food Safety Kits for Detecting Pathogenic Contaminants with Glucosaminidase ActivityManufacturers of food pathogen detection systems employ the compound as a chromogenic marker in rapid test cassettes and dipstick formats, targeting bacteria with unique N-acetyl-β-D-glucosaminidase profiles. The substrate is immobilized on membranes or paper-strip supports. Strict food testing standards require absence of background staining and clear endpoint color, achieved by optimizing substrate loading and stabilization additives during kit production. Shelf-life and transport stability are verified under accelerated conditions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-Beta-D-Glucosaminide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch we make of 5-Bromo-4-Chloro-3-Indolyl-N-Acetyl-Beta-D-Glucosaminide (BCIG-NAc-GlcNAc) comes straight from our core manufacturing line, overseen by experts who engage with both bench science and the technical guts of chemical synthesis. Years of hands-on production guide every run. We monitor reaction stages closely, choosing solvents and fine-tuning parameters based on what’s worked in both small and multi-kilogram batches. Others may simply repackage or relay product between entities — those chemicals often show broader lot-to-lot variability. Our on-site team controls key steps, from indole precursor selection to the final purification. This means our BCIG-NAc-GlcNAc maintains consistent chromogenic response and purity, traceable not only to analytical sheets but visible in the color clarity during your actual assay.
In diagnostics, histochemistry, and substrate screening, BCIG-NAc-GlcNAc offers a reliable chromogenic output without drifting shades or background. Customers rely on the substrate for beta-N-acetylglucosaminidase detection. To reach this exact level of utility, supply chain security matters. From our end, raw ingredients get audited, water content measured, and optical density checked at each stage. We calibrate milling and drying protocols using feedback from end-users who want clear blue signals in plate-based beta-hexosaminidase assays. If we see unexpected by-products or off tones, we don’t pass that batch onto the next step. These internal gates cut out the cycles of troubleshooting often seen with lesser-controlled sources. Over the last decade, labs using our substrate have reported fewer false positives and lower batch-to-batch color variation, often after switching from resellers.
From our plant, most customers want BCIG-NAc-GlcNAc as a freeze-dried solid, typically in low-gram to multi-kilogram lots. Why? The solid format keeps stability during transit, and long-term storage holds up at 2–8°C. Specific surface area and granule size come up often, especially when prepping media blends or looking for rapid dissolution. In our operation, we can control the final powder’s bulk density to suit liquid handling robots or manual pipetting. For those blending into agar plates, our hands-on QC techs use batchwise solubility assays to ensure quiet background and even color spread. Almost every specification — from moisture content to color to HPLC profile — gets set by actual feedback from microbiologists, not marketing teams.
Over the years, we’ve seen a broad range of customers put BCIG-NAc-GlcNAc to work. Medical researchers using it for lysosomal storage disorder screening value the sharp blue product formed during enzymatic cleavage. Plant biologists mixing it in vitro need stable substrate that survives longer incubations. In enzyme evolution programs, swift and reliable color formation makes it easier to spot high-activity mutants. We’ve responded to issues as they arise — for example, reformulating to lower background tints or adjusting storage vials to avoid static cling at small-scale. This feedback-driven improvement leads to a fine-tuned product that actually fits the work scientists do daily.
BCIG-NAc-GlcNAc sits in a class of indolyl substrates designed for enzymatic detection, but real-world results hinge on more than chemical formula. Straightforward purification keeps impurities under control, cutting down the risk of false background staining. Other products, especially those passed through multiple hands, may accumulate trace contaminants or show inconsistent indole substitution patterns. We favor high flash chromatography and advanced crystallization controls over minimal filtration — the extra cost saves labs endless troubleshooting.
Some related substrates, such as X-GlcNAc, yield precipitation or less vivid color; others might require extra additives or stabilizers to keep signal strong. Our BCIG-NAc-GlcNAc needs no color enhancers under typical lab conditions. In head-to-head tests run with customers, our substrate forms cleaner, sharper blue compared to alternatives with similar substitutions but weaker reaction conversions. The structure, with its bromo and chloro groups at precise positions, gives higher specificity for beta-N-acetylglucosaminidase. This reduces side-activity seen with less selective indolyl substrates.
Researchers consistently cite challenges in reproducibility, especially when working with off-brand products. From an industry standpoint, several factors shape the way our substrate performs. Solvent choice during synthesis can alter the batch’s crystalline habit and shelf life. Many laypersons underestimate the need for exacting evaporative control — too rapid yields amorphous powder that clumps and resists redissolving, while poor water removal lets hydrolysis creep in over time. Over years in fine chemical manufacturing, we’ve developed tools for gentle solvent stripping and staged drying. We cross-check each drum against UV/Vis, HPLC, and mass spec targets, with limits stricter than casual traders maintain.
Our labs have reviewed side-by-side results with academic partners tackling rare lysosomal enzyme variants. They tell us the difference in signal/noise often saves them days of repeat work. Over a hundred publications cite use of our material by catalog number, tying high purity and activity directly to published protocols.
The best ideas come from the end-users who send samples back and ask for tweaks. We work with many industrial QC groups and university core labs, receiving real feedback on substrate solubility, color formation speed, and edge-case stability. Once a major research hospital flagged faint blue haze in a large screening — an environmental contaminant picked up from packaging. We bootstrapped a new final filtration step to trap trace volatiles and changed container liners within weeks.
Another example came from food science researchers who process large plates for fungal chitinase assays. They needed low-dust, free-flowing powder handling dozens of plates at a time. Our engineers altered the granule cut to a tighter mesh size, which cut down on static carry-over and let machines run without constant cleaning. No amount of third-party outsourcing matches this responsiveness, only possible by running our own manufacturing and QC lines onsite.
Laboratories expect traceability — not just in the narrow sense of paperwork, but as a matter of knowing who produced each batch, how, and when. Our compliance managers keep batch records accessible and transparent, conforming to good manufacturing practices recognized by both local and international authorities. Regular audits by visiting scientists, not just in-house, hold us accountable for contamination, heavy metals, residual solvents, and even lot-specific assay curves. These standards emerge not from checklists but decades of back-and-forth with regulatory and clinical users asking hard questions.
This input helps us exceed thresholds for assay-grade purity, especially related to residual solvents, heavy metals, and trace toxicants. Routine batches run through additional testing needed for IVD (in vitro diagnostic) submission, giving customers extra data for any downstream regulatory filings. Each shipment includes full analytical info, but goes further — we flag unusual peaks immediately and offer custom splits or remedial runs before shipment if a customer faces an urgent verification window.
Running a specialty chemical synthesis line does not just rely on automation or analytics. Our staff includes engineers with decades of organic chemistry, not just button-pushers. Over years of synthesizing sensitive indole-derivatives, we’ve kept our teams trained on potential pitfalls — such as air oxidation, breakdown in high humidity, and impact of microbatch temperature fluctuations. Each challenge met in the past gives our techs intuition and tricks: a color shift on TLC, a subtle shift in NMR, or a baseline creep on HPLC leads to process adjustment, not handwaving.
Many distractions can creep in at scale, from raw material fraud to subtle changes in glassware. To stay ahead of these risks, we run quarterly cross-lab validations, comparing lots shipped five years ago to current releases. If drift appears, we trace root source and publish corrected protocols, sharing them openly with the research communities that rely on us.
Research is global, but problem-solving often happens locally. We export to dozens of countries and work with a wide range of users — from rural diagnostic clinics setting up new enzyme campaigns, to multinational R&D teams refining gene-based enzyme screens. The direct factory-to-lab supply chain simplifies logistics, but more importantly cuts down wait times when novel applications demand tweaks. Shipments cleared customs with pre-submitted documentation avoids delays, but also means product comes from the batch you expect, not a mystery lot with mismatched paperwork.
Some of our longest customer relationships exist because we listen—an institute in Singapore asked for single-use ampoule filling to cut wastage in hot climates, and we built a pilot line within the same year. Over time, partnerships like these underpin a global presence built on trust, not just price or catalog listings.
Most substrate users focus on the outcome: a reliable, visible chromogenic reaction. Yet every detail steps back to manufacturing. Solvent residues, batch aging, and even packaging reform can sway signal clarity and shelf life. Each year, our R&D unit reviews aggregate customer feedback and field tests alternative routes — sometimes trialing greener solvents, sometimes revisiting drying techniques, sometimes rechecking shelf-life under stress.
In the past, color signaling strength lagged with longer storage at high humidity. By moving to double-layer barrier bags and adjusting micron size, we helped customers in subtropical regions keep same signal over 12-18 months, without resorting to chilled air-freight. Adjustments like this begin with customer emails, not marketing pitches. Unexpected error spikes post-shipping? We recalibrate to meet reality, not just specification.
Lab scientists face enough headaches without unreliable reagents. Every delayed or failed batch tacks on hidden costs — lost sample, staff time, and missed deadlines. We know, because our own QC and development teams depend on the same substrate for internal validation work. When BCIG-NAc-GlcNAc forms the backbone of a critical screen, a bad lot isn’t just a hassle. By keeping synthesis, purification, and testing in-house, we can spot and reroute any off-batch before it complicates downstream work. Simple issues, like slightly altered shade or dustiness, spark troubleshooting immediately. Our staff has learned that the true long-term savings never come from cutting corners or passing off batch deviations.
Researchers, especially those fielding regulatory audits or publishing in peer-reviewed settings, keep tabs on data integrity. Visibility, signal stability, and lot information that match reported specifications means published results stand up to challenge. Reproducibility, a daily concern for biologists, improves when assay substrates perform batch after batch.
Every chromogenic substrate has strengths and weak spots. BCIG-NAc-GlcNAc forms clean, stable blue color, easy to quantify visually or spectrophotometrically, even at low enzyme concentrations. This feature lets researchers run both endpoint and kinetic readings without recalibrating each run. While older substrates sometimes need extra development time, or show faint tints before enzymatic cleavage, our material yields sharp, low-background blanks right out of the tube.
Some competing products replace the bromo or chloro group to save on raw material cost. We’ve found these tweaks drop reaction specificity or increase side-color, especially on difficult samples. Adulteration, as seen in lower-cost suppliers, leads to troublesome spots where multiple colors may bleed into assays. Regular users confirm better predictive response curves and easier downstream data analysis with our factory-line substrate.
Our shop floor isn’t rows of robots — it’s chemists, engineers, and materials specialists dedicated to careful, accountable synthesis. Missteps aren’t covered up or rerouted; every failed run becomes training and data for improvement. The person blending your BCIG-NAc-GlcNAc may have forty years in indole derivatives, and their insight fills more feedback reports than any algorithm. We know not every batch comes easy. At scale, temperature spikes, container design, or small pH drifts can make or break final product performance.
That experience extends from purchasing right through package design. We use screw-cap amber vials for field shipments, knowing sunlight and moisture both chip away at shelf-life. Labels come with QR-coded batch data, not hand-written numbers, so you don’t spend half a day chasing paperwork.
Producing BCIG-NAc-GlcNAc at scale brings tough choices; balancing purity, cost, and performance isn’t simple. Over time, we’ve learned to keep direct communication lines with both small labs and major buyers. Just last quarter, we overhauled an entire synthesis stage after a key supplier changed raw indole grade, followed by closing that feedback loop through sample exchanges with three partner sites. Upstream controls, hands-on edits, and reflective quality checks yield substrate that fits researchers’ needs for consistent, no-surprise behavior.
In our factory, every bottle represents not just a shipment, but years of technical troubleshooting, customer conversations, and hard-won expertise. We sell BCIG-NAc-GlcNAc because we believe skilled process — not just formula — unlocks real progress in life science workflows.